March 07, 2017
1 min read

Researchers identify three new candidate genes in RA pathogenesis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Through integration of RNA-sequencing data with association study findings, researchers identified ERBB2, TP53 and THOP1 as new candidate genes in the pathogenesis of rheumatoid arthritis.

In the blood cells of five patients newly diagnosed with rheumatoid arthritis (RA), seven patients with treated RA and 12 healthy controls, Leonid Padyukov, MD, PhD, a researcher and group leader in the Rheumatology Unit of the Karolinska Institute in Sweden, and colleagues performed RNA-sequencing-based expression analysis of 377 genes from loci previously associated with RA. For pathway analysis, they selected 11 differentially expressed genes with a similar expression pattern in treated and untreated RA. In a set of 56 connector genes derived from pathway analysis, they tested for differential expression in the initial discovery cohort and then validated expression in peripheral blood mononuclear cells from 73 patients with RA and 35 healthy controls.

Researchers found differential expression of ERBB2, TP53 and THOP1 was similar in both patients treated and untreated for RA. Compared with healthy controls, an additional nine genes were differentially expressed in at least one group of patients. In an independent collection of blood cell samples from healthy controls and non-treated patients with RA, the expression profiles of the three genes were replicated in RNA-sequencing data. – by Will Offit

Disclosure: The researchers report funding from The Swedish Research Council and Be The Cure consortium.